Treatment
Recombinant Botulinum Toxin Type A clinical trials
We’re tracking 4 recruiting studies that include Recombinant Botulinum Toxin Type A, each written for real people, not researchers, below.
Recruiting studies
- NCT06783114RecruitingPhase 2/Phase 3
Testing a new Botox-like injection for arm stiffness after stroke
This study tests an investigational botulinum toxin injection (YY001) to reduce muscle stiffness in the arm after a stroke. It may help you move your arm more easily and improve daily tasks.
Hefei, AnhuiAges 18–75 - NCT07478822RecruitingPhase 3
Botulinum toxin study for arm spasticity after stroke
This study tests a new botulinum toxin injection (YY001) for adults whose arm muscles are tight or stiff after a stroke. It looks at whether repeated treatments help with daily activities like washing and dressing.
BeijingAges 18–75 - NCT06937944RecruitingPhase 3
New Botox-like injection for frown lines
This study tests a new botulinum toxin injection (similar to Botox) to see how well it smooths moderate to severe frown lines between the eyebrows. The treatment is given as a single injection and may help soften those lines for several months.
Beijing, Beijing MunicipalityAges 18–65 - NCT07242300RecruitingPhase 3
Testing a new botulinum toxin for arm stiffness after stroke
This trial tests a new injectable medication (Eveotox) to see if it can safely reduce arm or hand stiffness in people who have had a stroke. The goal is to improve daily activities like dressing or cleaning your hand.
Beijing, Beijing MunicipalityAges 18–80
What Recombinant Botulinum Toxin Type A is being studied for
Conditions with recruiting Recombinant Botulinum Toxin Type A studies.
Common questions
- Are there clinical trials studying Recombinant Botulinum Toxin Type A?
- Yes. Clin2 currently lists 4 recruiting studies that include Recombinant Botulinum Toxin Type A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Recombinant Botulinum Toxin Type A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Recombinant Botulinum Toxin Type A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Recombinant Botulinum Toxin Type A or a specific trial is right for you.
Related treatments
- Botulinum toxin type A
- Botulinum Neurotoxin Type A
- Recombinant Human Adenovirus Type 5
- Recombinant Granulocyte Colony-Stimulating Factor
- Recombinant Respiratory Syncytial Virus Vaccine
- Recombinant Human Growth Hormone
- Recombinant Herpes Zoster Vaccine
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1
- recombinant humanized anti-CD25 monoclonal antibody
- Recombinant human erythropoietin
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.